Medline Inc. is 29.7x more valuable than PROCEPT BioRobotics Corp by market capitalization ($49.12 B vs $1.65 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | PRCT | MDLN |
|---|---|---|
| Market cap | $1.65 B | $49.12 B |
| US-listed rank | #2246 | #322 |
| Revenue (latest FY) | $308.05M | $28.43B |
| Net income (latest FY) | -$95.57K | $1.16T |
| Net margin | -0.0% | 4069.4% |
| P/E (trailing FY) | - | 0.0 |
| SEC filings | 360 | 103 |
Medline Inc. is 29.7x more valuable than PROCEPT BioRobotics Corp by market capitalization ($49.12 B vs $1.65 B).
In their latest fiscal years, PROCEPT BioRobotics Corp reported $308.05M in revenue while Medline Inc. reported $28.43B.
Full pages: PROCEPT BioRobotics Corp and Medline Inc., or browse the full rankings.